Literature DB >> 22125028

Analysis of human Ki-67 gene promoter and identification of the Sp1 binding sites for Ki-67 transcription.

Dong-Sheng Pei1, Guo-Wei Qian, Hui Tian, Jie Mou, Wang Li, Jun-Nian Zheng.   

Abstract

Ki-67 as a cell proliferation marker is tightly associated with maintenance and regulation of the cell division. To understand the mechanism of Ki-67 gene expression and regulation, we first cloned 5'-flanking region and identified the Ki-67 core promoter. The deletion analysis and the dual luciferase reporter assay were used to locate the Ki-67 core promoter from -223 to +12 nt relative to the transcriptional initiation site, which is the TATA less, GC rich region comprised of several putative Sp1 binding sites. Compared with the hTERT promoter and Survivin promoter, the Ki-67 core promoter possessed higher transcription activity and more desirable tumor selectivity. In order to further demonstrate the contribution of transcription factor Sp1 on regulating the Ki-67 gene transcription, we confirmed three Sp1 binding sites from -170 to -145 nt, from -63 to -38 nt, and from -14 to +12 nt existed in the Ki-67 core promoter by the supershift assay. The deletion mutagenesis, together with the dual luciferase reporter assay, indicated that these Sp1 binding sites, particularly the region from -170 to -145 nt, were involved in positive regulation of the Ki-67 gene expression. Collectively, it was demonstrated that the region from -223 to +12 nt could drive the transcription of the Ki-67 gene, and the Sp1 binding site is essential to transcriptional regulation of the Ki-67 gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22125028     DOI: 10.1007/s13277-011-0277-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  26 in total

1.  Biochemical characterization of pKi67 with the identification of a mitotic-specific form associated with hyperphosphorylation and altered DNA binding.

Authors:  D E MacCallum; P A Hall
Journal:  Exp Cell Res       Date:  1999-10-10       Impact factor: 3.905

Review 2.  Methyl CpG-binding proteins and transcriptional repression.

Authors:  P A Wade
Journal:  Bioessays       Date:  2001-12       Impact factor: 4.345

Review 3.  The Ki-67 protein: from the known and the unknown.

Authors:  T Scholzen; J Gerdes
Journal:  J Cell Physiol       Date:  2000-03       Impact factor: 6.384

Review 4.  Nuclear receptor-mediated transactivation through interaction with Sp proteins.

Authors:  Stephen Safe; Kyounghyun Kim
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2004

Review 5.  Conservation and divergence in eukaryotic DNA methylation.

Authors:  Tzuu-Fen Lee; Jixian Zhai; Blake C Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

6.  Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.

Authors:  Howard J Goldberg; Catharine I Whiteside; Gerald W Hart; I George Fantus
Journal:  Endocrinology       Date:  2006-01       Impact factor: 4.736

7.  The human luteinizing hormone receptor gene promoter: activation by Sp1 and Sp3 and inhibitory regulation.

Authors:  Y Geng; C H Tsai-Morris; Y Zhang; M L Dufau
Journal:  Biochem Biophys Res Commun       Date:  1999-09-24       Impact factor: 3.575

8.  Dopamine receptor regulating factor, DRRF: a zinc finger transcription factor.

Authors:  C K Hwang; U M D'Souza; A J Eisch; S Yajima; C H Lammers; Y Yang; S H Lee; Y M Kim; E J Nestler; M M Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

9.  Sp1 elements protect a CpG island from de novo methylation.

Authors:  M Brandeis; D Frank; I Keshet; Z Siegfried; M Mendelsohn; A Nemes; V Temper; A Razin; H Cedar
Journal:  Nature       Date:  1994-09-29       Impact factor: 49.962

10.  Involvement of PKA and Sp1 in the induction of p27(Kip1) by tamoxifen.

Authors:  Te-Hsiu Lee; Hui-Chiu Chang; Lea-Yea Chuang; Wen-Chun Hung
Journal:  Biochem Pharmacol       Date:  2003-08-01       Impact factor: 5.858

View more
  7 in total

1.  A dual-regulated oncolytic adenovirus expressing interleukin-24 sensitizes melanoma cells to temozolomide via the induction of apoptosis.

Authors:  Guan Jiang; Ai-Jun Jiang; Qian Cheng; Hui Tian; Lian-Tao Li; Jun-Nian Zheng
Journal:  Tumour Biol       Date:  2013-02-21

2.  IRF1 suppresses Ki-67 promoter activity through interfering with Sp1 activation.

Authors:  Feifei Chen; Jian Song; Jiehui Di; Qing Zhang; Hui Tian; Junnian Zheng
Journal:  Tumour Biol       Date:  2012-08-14

Review 3.  Ki67 targeted strategies for cancer therapy.

Authors:  C Yang; J Zhang; M Ding; K Xu; L Li; L Mao; J Zheng
Journal:  Clin Transl Oncol       Date:  2017-10-20       Impact factor: 3.340

4.  Potent anti-tumour activity of a novel conditionally replicating adenovirus for melanoma via inhibition of migration and invasion.

Authors:  G Jiang; C-S Yang; D Xu; C Sun; J-N Zheng; T-C Lei; Y-Q Liu
Journal:  Br J Cancer       Date:  2014-04-08       Impact factor: 7.640

5.  Reciprocal Role Of DNA Methylation And Sp1 Binding In Ki-67 Gene Transcription.

Authors:  Lian-Tao Li; Xun Wang; Wen-Tao Zhu; Guo-Wei Qian; Dong-Sheng Pei; Jun-Nian Zheng
Journal:  Cancer Manag Res       Date:  2019-11-18       Impact factor: 3.989

6.  Dysregulation of Ki-67 Expression in T Cells of Children with Autism Spectrum Disorder.

Authors:  Khaled Alhosaini; Mushtaq A Ansari; Ahmed Nadeem; Sabry M Attia; Saleh A Bakheet; Laila Y Al-Ayadhi; Hafiz M Mahmood; Haneen A Al-Mazroua; Sheikh F Ahmad
Journal:  Children (Basel)       Date:  2021-02-06

Review 7.  The intrinsically disorderly story of Ki-67.

Authors:  Lucy Remnant; Natalia Y Kochanova; Caitlin Reid; Fernanda Cisneros-Soberanis; William C Earnshaw
Journal:  Open Biol       Date:  2021-08-11       Impact factor: 6.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.